Table 4.
Attrition rates by LOT
| LOT | Frequency, N | Attrition, % | Deaths, n (%) | No subsequent treatment in follow-up, n (%) | Subsequent treatment, n (%) | Mean ± SD treatment duration, months (median) |
|---|---|---|---|---|---|---|
| Non-transplant | ||||||
| 1 | 22,062 | – | 2841 (12.9) | 9716 (44.0) | 9505 (43.1) | 6.9 ± 9.6 (3.6) |
| 2 | 9505 | 56.9 | 1155 (12.2) | 3168 (33.3) | 5182 (54.5) | 7.5 ± 9.5 (4.1) |
| 3 | 5182 | 45.5 | 636 (12.3) | 1575 (30.3) | 2971 (57.3) | 6.5 ± 8.0 (3.7) |
| 4 | 2971 | 42.7 | 364 (12.3) | 901 (30.3) | 1706 (57.4) | 5.7 ± 6.6 (3.4) |
| 5 | 1706 | 42.6 | 209 (12.3) | 508 (29.8) | 989 (58.0) | 5.5 ± 6.4 (3.2) |
| Transplant | ||||||
| 1 | 2763 | – | 36 (1.3) | 543 (19.6) | 2184 (79.0) | 6.3 ± 8.0 (4.2) |
| 2 | 2184 | 21.0 | 60 (2.7) | 613 (28.1) | 1511 (69.2) | 6.1 ± 9.2 (2.7) |
| 3 | 1511 | 30.8 | 63 (4.2) | 494 (32.7) | 954 (63.1) | 7.4 ± 9.8 (3.6) |
| 4 | 954 | 36.9 | 60 (6.3) | 276 (28.9) | 618 (64.8) | 6.6 ± 9.4 (3.4) |
| 5 | 618 | 35.2 | 49 (7.9) | 180 (29.1) | 389 (62.9) | 5.6 ± 6.2 (3.3) |
LOT Line of therapy, SD Standard deviation